Table 1. Clinical and laboratory characteristics of individuals with type 2 diabetes, initial parameters of InsulinAPP protocol and follow-up.
| Variable | Type 2 DM (n = 147) | ||
|---|---|---|---|
| Sex | |||
| Male | 87 (59.6%) | ||
| Female | 59 (40.4%) | ||
| Age, years | 62.3 ± 12.7 | ||
| BMI, kg/m2 | 27.2 ± 5.9 | ||
| Admission cause | |||
| Medicine | 34 (23.1%) | ||
| Surgery | 113 (76.9%) | ||
| eGFR, mL/min/1.73 m2 | 71.6 ± 30.7 | ||
| Serum creatinine, mg/dL | 1.3 ± 1.0 | ||
| Admission BG, mg/dL | 220.3 ± 92.9 | ||
| HbA1c, % | 8.3 ± 3.0 | ||
| InsulinAPP protocol | |||
| Initial insulin regimen | |||
| Basal-bolus | 69 (46.7%) | ||
| Bolus-correction | 73 (49.7%) | ||
| SSI | 5 (3.4%) | ||
| Initial TDD, units/kg/day | |||
| Basal-bolus | 0.37 ± 0.14 | ||
| Bolus-correction | 0.13 ± 0.03 | ||
| Follow-up | |||
| Hospital discharge | 134 (91.2%) | ||
| Transfer to another ward | 20 (13.6%) | ||
| ICU transfer | 8 (5.4%) | ||
| Indication of palliative care | 6 (4.1%) | ||
| Deaths | 13 (8.8%) | ||
Data are mean ± SD or n (%).
BG: blood glucose; BMI: body mass index; eGFR: estimated glomerular filtration rate (CKD-EPI); ICU: intensive care unit; SSI: sliding scale insulin; TDD: total daily dose of insulin.